Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Katharina Wiest"'
Autor:
Jordon D. Bosse, Kim Hoffman, Katharina Wiest, P. Todd Korthuis, Ritwika Petluri, Kellie Pertl, Stephen A. Martin
Publikováno v:
Addiction Science & Clinical Practice, Vol 17, Iss 1, Pp 1-11 (2022)
Abstract Background People with opioid use disorder (OUD) face barriers to entering and remaining in life-saving treatment (e.g., stigma, detrimental interactions with health care, and privacy concerns). Telehealth and related technology can reduce b
Externí odkaz:
https://doaj.org/article/12b7e3c36d9542348cf4d612629dd514
Autor:
Kellie Pertl, Ritwika Petluri, Katharina Wiest, Kim Hoffman, Dennis McCarty, Ximena A. Levander, Brian Chan, Stephen A. Martin, P. Todd Korthuis
Publikováno v:
Contemporary Clinical Trials Communications, Vol 31, Iss , Pp 101043- (2023)
Background: The COVID-19 pandemic presents challenges in participant recruitment strategies for clinical research involving people with opioid use disorders recently engaged in treatment. We describe challenges to participant recruitment in a trial c
Externí odkaz:
https://doaj.org/article/fd2a1074269d4530a24d53619c7d1929
Autor:
Kellie Pertl, Ritwika Petluri, Katharina Wiest, Kim Hoffman, Dennis McCarty, Ximena A. Levander, Brian Chan, Stephen A. Martin, P. Todd Korthuis
Publikováno v:
Contemporary clinical trials communications. 31
The COVID-19 pandemic presents challenges in participant recruitment strategies for clinical research involving people with opioid use disorders recently engaged in treatment. We describe challenges to participant recruitment in a trial comparing vir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cd6b6b2f001d5ff3b0b1b1df9c6f43c
https://pubmed.ncbi.nlm.nih.gov/36475092
https://pubmed.ncbi.nlm.nih.gov/36475092
Autor:
Joy M. Schmitz, Kathy Shores-Wilson, Mora Kim, Adriane M. dela Cruz, Sidarth Wakhlu, Udi E. Ghitza, Thomas Carmody, Aimee Wahle, Walter Ling, Steven Shoptaw, A. John Rush, Katharina Wiest, Steven Sparenborg, Gavin Bart, Susan C. Sonne, Phillip O. Coffin, Robrina Walker, Madhukar H. Trivedi, Gaurav Sharma, Edward V. Nunes
Publikováno v:
N Engl J Med
BACKGROUND: The use of naltrexone plus bupropion to treat methamphetamine use disorder has not been well studied. METHODS: We conducted this multisite, double-blind, two-stage, placebo-controlled trial with the use of a sequential parallel comparison
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be15f1d4738f56ee62304c6850363723
https://doi.org/10.1056/nejmoa2020214
https://doi.org/10.1056/nejmoa2020214
Autor:
Michael Giles, Lucy Reynales, Avinash Jayaraman, Omer Kaplan, Kshitij Verma, Katharina Wiest, Kim A. Hoffman, Dongseok Choi, Mark McGovern, Dennis McCarty
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1347f104ea21a2a8042ec23fece09cfe
https://doi.org/10.2139/ssrn.4258702
https://doi.org/10.2139/ssrn.4258702
Autor:
Ioana Adriana Muntean, Ioana Corina Bocsan, Lena Katharina Wiest, Irena Pintea, Carmen Teodora Dobrican, Emanuela Duca, Corina Ureche, Anca Dana Buzoianu, Diana Deleanu
Publikováno v:
Nutrients, Vol 14, Iss 494, p 494 (2022)
Nutrients; Volume 14; Issue 3; Pages: 494
Nutrients; Volume 14; Issue 3; Pages: 494
Aim: The present study analyzed clinical and biological factors that might predict achievement of tolerance in patients with IgE-mediated cow milk allergy (CMA). Method: Seventy patients with IgE-mediated CMA (44.24 ± 24.16 months) were included in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc82daa78ddfb1f1bffe727d585194f6
https://www.mdpi.com/2072-6643/14/3/494
https://www.mdpi.com/2072-6643/14/3/494
Autor:
Vishaal Mehra, James L. Andersen, Michael J. Biunno, Jelena Kunovac, Walter Ling, Barbara R. Haight, Saleem Ishaque, David R. Hassman, Gregory Seal, Scott Daniel Segal, Amanda S. Garofalo, Jesse M. Carr, Valentin Isacesu, Rakesh Ranjan, Ricky Stuart Mofsen, Otto R. Dueno, Kent Steven Hoffman, Paul J. Fudala, Brent Boyett, Shishuka Malhotra, Lawrence S. Levinson, Céline M. Laffont, Peter Paul Ventre, Eduardo Cifuentes, Sandra Daniela Duarte-Sckell, Scott Robert Bartley, Genie L. Bailey, Richard D. Knapp, Gita G. Pujari, Kyle M. Kampman, Rajinder Shiwach, Christian Heidbreder, Vijay R Nadipelli, Daniel Rutrick, Y Zhao, Rishi Kakar, Katharina Wiest, Marvin Lane Peyton, David P. Walling, Susan M Learned, Joseph A. Kwentus, Amit K. Vijapura, Haydn Mikel Thomas, Boyde J. Harrison, Mark K. Greenwald, George Konis
Publikováno v:
The Lancet. 393:778-790
RBP-6000, referred to as BUP-XR (extended-release buprenorphine), is a subcutaneously injected, monthly buprenorphine treatment for opioid use disorder. BUP-XR provides sustained buprenorphine plasma concentrations to block drug-liking of abused opio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d956456416ef2fa898c563ec73fed86b
https://doi.org/10.1016/s0140-6736(18)32259-1
https://doi.org/10.1016/s0140-6736(18)32259-1
Autor:
Susan M Learned, Lori McLeod, Y Zhao, Christian Heidbreder, Anne Le Moigne, Lauren Nelson, Katharina Wiest, Brent Boyett, Paul J. Fudala, Warren K. Bickel
Publikováno v:
Drug and Alcohol Dependence. 229:109057
Background This work evaluated the psychometric properties of the single-item Opioid Craving Visual Analog Scale (OC-VAS) for opioid use disorder (OUD). Methods Psychometric evaluation of the OC-VAS (range: 0–100 mm) was supported by Subjective Opi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2be2a592de22f993d30df503e6a6b60f
https://doi.org/10.1016/j.drugalcdep.2021.109057
https://doi.org/10.1016/j.drugalcdep.2021.109057
Autor:
John S. Baer, Blair Beadnell, Kasie Cloud, Michelle Peavy, Lynette Wright, Robin Harwick, Katharina Wiest, Audra Robinson, Elizabeth A. Wells, Kathleen Dillon, Mary A. Hatch-Maillette, Tatiana Masters
Publikováno v:
Drug Alcohol Depend
Background People with substance use disorder (SUD) experience increased risk for HIV, Hepatitis C, and sexually transmitted illnesses via risky sex. This high-risk population would benefit from sexual risk reduction interventions integrated into SUD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43bb056189edfd3815be9f0eb896bd24
https://europepmc.org/articles/PMC6759210/
https://europepmc.org/articles/PMC6759210/
Autor:
Christie Thomas, Stephen Ross, William Swafford, P. Todd Korthuis, Carolyn Schuman, Gregory S. Brigham, Abigail G. Matthews, Larissa J. Mooney, Steve Sparenborg, Maureen Hillhouse, Michael A. Dawes, Karen Drexler, David Liu, William Lawson, Sarah Church, Andrew J. Saxon, Walter Ling, Patricia C. Knox, John Rotrosen, Jennifer McCormack, Alfonso Ang, Jeffrey J. Annon, Albert Hasson, Katharina Wiest
Publikováno v:
Addiction. 111:1416-1427
Aims To examine the safety and effectiveness of buprenorphine + naloxone sublingual tablets (BUP, as Suboxone(®) ) provided after administration of extended-release injectable naltrexone (XR-NTX, as Vivitrol(®) ) to reduce cocaine use in participan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::453bad8536ff6c82a961dbc70dc62290
https://doi.org/10.1111/add.13375
https://doi.org/10.1111/add.13375